In contrast, another study in T2DM patients found that using continuous subcutaneous insulin infusion (CSII) and CGM significantly reduced ED severity, supporting the idea that decreased glycemic variability could mitigate ED risk in T1D as well [66]. This evidence concerns the gene INS and type 1 diabetes mellitus.